Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia

Por Eggan, Stephen M., Hashimoto, Takanori, Lewis, David A.
Publicado em 2008

Alterations in Metabotropic Glutamate Receptor 1α and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia

Por Volk, David W., Eggan, Stephen M., Lewis, David A.
Publicado em 2010

Development of Cannabinoid 1 Receptor Protein and Messenger RNA in Monkey Dorsolateral Prefrontal Cortex

Por Eggan, Stephen M., Mizoguchi, Yoshito, Stoyak, Samuel R., Lewis, David A.
Publicado em 2010

Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder

Por Eggan, Stephen M, Stoyak, Samuel R, Verrico, Christopher D, Lewis, David A
Publicado em 2010

Relationship of Cannabinoid CB1 Receptor and Cholecystokinin Immunoreactivity in Monkey Dorsolateral Prefrontal Cortex

Por Eggan, Stephen M., Melchitzky, Darlene S., Sesack, Susan R., Fish, Kenneth N., Lewis, David A.
Publicado em 2010

Reciprocal Alterations in Cortical Cannabinoid Receptor 1 Binding Relative to Protein Immunoreactivity and Transcript Levels in Schizophrenia

Por Volk, David W., Eggan, Stephen M., Horti, Andrew, Wong, Dean F., Lewis, David A.
Publicado em 2014

Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: Implications for schizophrenia

Por Curley, Allison A., Eggan, Stephen M., Lazarus, Matt S., Huang, Z. Josh, Volk, David W., Lewis, David A.
Publicado em 2012

Cortical GAD(67) deficiency results in lower cannabinoid 1 receptor mRNA expression: Implications for schizophrenia

Por Eggan, Stephen M., Lazarus, Matthew S., Stoyak, Samuel R., Volk, David W., Glausier, Jill R., Huang, Z. Josh, Lewis, David A.
Publicado em 2011